Papers › Human genetic evidence is associated with drug approval across therapeutic areas: an...

Human genetic evidence is associated with drug approval across therapeutic areas: an observational analysis of 26,278 target-disease pairs with temporal validation and feature ablation

12 Jun 2026arXiv:2606.14823added by Syntology

Victoria Paterson

Title, abstract, authors and date from arXiv's metadata (CC0); this paper is not in the Papers with Code archive (frozen 2025-07-28).

Genetic evidence is enriched among approved drug targets: in an observational analysis of 26,278 target-disease pairs from Open Targets and ChEMBL, targets with any genetic association had a 3.25-fold higher approval rate than those without (OR = 3.25, 95% CI 2.79-3.79, p = 1.91e-42). A target-level analysis accounting for non-independence of pairs sharing the same gene gave OR = 2.79 (bootstrap 95% CI 2.22-3.53); the oncology pair-level OR of 6.72 attenuates to 2.71 at the target level, illustrating how non-independence inflates area-specific estimates. The enrichment replicated in post-2015 approvals (OR = 3.51, p = 1.72e-8). Feature ablation across six evidence types revealed that literature mining alone accounts for most classifier performance (AUPRC = 0.099 versus 0.109 for all features), consistent with temporal leakage from post-approval publications. Excluding literature, remaining evidence types retain above-baseline signal (AUPRC = 0.084, 1.63x baseline). Sensitivity analyses bracket the pair-level OR between 3.25 and 4.93. Genetic evidence alone yields only a 1.0-percentage-point absolute AUPRC gain and the best model has poor calibration; the classifier has limited practical predictive value. We catalogue 1,433 genetically supported Phase 1/2 pairs as a hypothesis-generating resource. All findings are observational.

PaperPDF

Code

vi-c-ky/Human-genetic-evidence-associated-with-Only found in paper text by Syntologynot reachable when probed 2026-09-16 — repositories for recent papers often appear after camera-ready report

Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.

Code Syntology ran Syntology

Syntology holds the repository link but has not harvested or run code from it.

Results from the paper

The Papers with Code archive ends with its 2025-07-28 snapshot. This paper's arXiv identifier, 2606.14823, was issued in June 2026, after that date, so the archive has no leaderboard rows for it.

Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections